Evotec SE Share Price Deutsche Boerse AG
Stocks
EVT
DE0005664809
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
13:02:32 07/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.834 EUR | -8.76% |
|
-9.69% | -48.10% |
| 10-06 | Investors seek stocks in diagnostics and laboratory sector | DP |
| 10-06 | Frankfurt Stocks Open Higher: Dax Rises After Positive Signals From US | DP |
| Market Cap | 522M 584M 487M 442M 832M 56.46B 839M 5.85B 2.28B 28.72B 2.19B 2.14B 92.31B | P/E 2026 * |
-2.3x | P/E 2027 * | -6.82x |
|---|---|---|---|---|---|
| Enterprise Value | 664M 744M 620M 563M 1.06B 71.93B 1.07B 7.45B 2.91B 36.58B 2.79B 2.73B 118B | EV / Sales 2026 * |
1.11x | EV / Sales 2027 * | 0.94x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| EVT | Delayed | |
CBOE
| EVTd | Real-time | |
|
Tradegate
| EVT | Real-time | |
|
Börse Stuttgart
| EVT | Delayed | |
|
Boerse Muenchen
| EVT | Real-time | |
|
Deutsche Boerse AG
| EVT | Delayed | |
|
Bulgaria S.E.
| EVT | End-of-day quote | |
|
London S.E.
| 0IRF | Delayed | |
|
OTC Markets
| EVOTF | Delayed | |
|
Borsa Italiana
| 1EVT | End-of-day quote | |
|
Wiener Boerse
| EVT | End-of-day quote | |
|
CBOE
| 0IRF | Real-time | |
|
Swiss Exchange
| EVT | Delayed |
Last Transcript: Evotec SE
| 1 day | -8.76% | ||
| 1 week | -9.69% | ||
| Current month | -9.69% | ||
| 1 month | -10.82% | ||
| 3 months | -44.86% | ||
| 6 months | -36.77% | ||
| Current year | -48.10% |
| 1 week | 2.83 |  | 3.11 |
| 1 month | 2.73 | | 3.19 |
| Current year | 2.73 | | 6.66 |
| 1 year | 2.73 | | 7.49 |
| 3 years | 2.73 | | 21.7 |
| 5 years | 2.73 | | 45.43 |
| 10 years | 2.73 | | 45.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 30/06/2024 | |
| Director of Finance/CFO | - | 30/04/2026 | |
Ingrid Müller
COO | Chief Operating Officer | - | 30/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 18/06/2019 |
| Director/Board Member | 64 | 31/05/2021 | |
Duncan McHale
BRD | Director/Board Member | 59 | 09/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.76% | -9.69% | - | - | 584M | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.68B | |
| +0.46% | -0.97% | +23.51% | +79.34% | 58.7B | |
| +0.17% | +0.35% | +6.85% | +34.55% | 48.36B | |
| +0.50% | -2.14% | +331.33% | +702.20% | 43.05B | |
| -0.72% | -3.99% | +28.50% | +29.94% | 42.48B | |
| +0.34% | -0.52% | +6.56% | +109.35% | 41.39B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.29B | |
| -0.50% | -3.10% | -10.19% | -14.35% | 23.93B | |
| -3.32% | -10.86% | -37.32% | +316.28% | 22.22B | |
| Average | -0.78% | -2.18% | +45.31% | +156.02% | 42.9B | |
| Weighted average by Cap. | +0.66% | -1.56% | +52.73% | +149.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 601M 673M 561M 509M 959M 65.06B 966M 6.74B 2.63B 33.09B 2.52B 2.47B 106B | 724M 810M 676M 614M 1.16B 78.4B 1.16B 8.12B 3.17B 39.87B 3.04B 2.98B 128B |
| Net income | -222M -248M -207M -188M -354M -24.03B -357M -2.49B -972M -12.22B -933M -913M -39.29B | -48.25M -54M -45.02M -40.89M -77.01M -5.22B -77.58M -541M -211M -2.66B -203M -198M -8.54B |
| Net Debt | 143M 160M 133M 121M 228M 15.47B 230M 1.6B 626M 7.87B 600M 587M 25.29B | 162M 181M 151M 137M 259M 17.56B 261M 1.82B 710M 8.93B 681M 667M 28.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/10/26 | €2.834 | -8.76% | 1,900 |
| 06/10/26 | €3.106 | +5.72% | 2,640 |
| 05/10/26 | €2.938 | +0.41% | 3,120 |
| 02/10/26 | €2.926 | -5.12% | 1,550 |
| 01/10/26 | €3.084 | -1.72% | 8,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EVT Stock
- EVT Stock
Select your edition
All financial news and data tailored to specific country editions
